However, one industry observer cautions against moving forward with specific GLP-1 claims on packaging until federal agencies ...
Novo Nordisk on Monday announced a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the ...
Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump ...
NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...
Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.
Below is a roundup of health tech and digital health news you may have missed | Keep up with some of the latest headlines in ...
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
The issuer is solely responsible for the content of this announcement.
A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...
At STAT's Breakthrough Summit East, the CEOs of Ro and Included Health said the the U.S. health care system poses obstacles ...
6d
MarketBeat on MSNIs Viking Therapeutics the Next Blockbuster GLP-1 Stock?When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...
Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss., ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results